These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 16026306)
1. CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies. More SA; Deore RS; Pawar HD; Sharma C; Nakhate KT; Rathod SS; Ojha S; Goyal SN Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338960 [TBL] [Abstract][Full Text] [Related]
2. Novel approaches and current challenges with targeting the endocannabinoid system. Morales P; Jagerovic N Expert Opin Drug Discov; 2020 Aug; 15(8):917-930. PubMed ID: 32336154 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases. Sharon N; Yarmolinsky L; Khalfin B; Fleisher-Berkovich S; Ben-Shabat S Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928109 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Cabral GA; Griffin-Thomas L Endocr Metab Immune Disord Drug Targets; 2008 Sep; 8(3):159-72. PubMed ID: 18782012 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Huffman JW; Thompson AL; Wiley JL; Martin BR Bioorg Med Chem; 2008 Jan; 16(1):322-35. PubMed ID: 17919913 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoids in the descending pain modulatory circuit: Role in inflammation. Bouchet CA; Ingram SL Pharmacol Ther; 2020 May; 209():107495. PubMed ID: 32004514 [TBL] [Abstract][Full Text] [Related]
8. A quantitative pharmacology model for cannabinoid CB Yang L; Finlay DB; Green HM; Zhu X; Glass M; Duffull S Br J Pharmacol; 2024 Apr; 181(8):1324-1340. PubMed ID: 38072805 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity. Abdollahzadeh Hamzekalayi MR; Hooshyari Ardakani M; Moeini Z; Rezaei R; Hamidi N; Rezaei Somee L; Zolfaghar M; Darzi R; Kamalipourazad M; Riazi G; Meknatkhah S Eur J Pharmacol; 2024 Aug; 976():176679. PubMed ID: 38821167 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in the Treatment of Neurological Disorders. Devinsky O; Whalley BJ; Di Marzo V Neurotherapeutics; 2015 Oct; 12(4):689-91. PubMed ID: 26334724 [No Abstract] [Full Text] [Related]
12. Nanotechnology enabled regenerative medicine for neurological disorders. Lowe TL; Agrahari V; Kannan RM; Kannan S Adv Drug Deliv Rev; 2019 Aug; 148():1-2. PubMed ID: 31787167 [No Abstract] [Full Text] [Related]
13. Could we co-opt the cannabinoid system for asthma therapy? Palomares O Expert Rev Clin Immunol; 2023; 19(10):1183-1186. PubMed ID: 37420178 [No Abstract] [Full Text] [Related]
14. Cannabinoids, the Heart of the Matter. Alfulaij N; Meiners F; Michalek J; Small-Howard AL; Turner HC; Stokes AJ J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006489 [No Abstract] [Full Text] [Related]
15. Modulatory mechanisms of cannabinoids as a window of hope to patients with sleep-related cardiometabolic risk. Meira E Cruz M Biomed Pharmacother; 2023 Dec; 168():115721. PubMed ID: 37852101 [No Abstract] [Full Text] [Related]
16. Cannabinoids. López-Rodríguez ML Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306 [No Abstract] [Full Text] [Related]
17. Therapeutic potential of cannabinoid receptor ligands: current status. Singh J; Budhiraja S Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344 [TBL] [Abstract][Full Text] [Related]
18. Microglial Cannabinoid CB Xu K; Wu Y; Tian Z; Xu Y; Wu C; Wang Z Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768668 [TBL] [Abstract][Full Text] [Related]
19. Focus on cannabinoids and synthetic cannabinoids. Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784 [TBL] [Abstract][Full Text] [Related]